These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 24013102)

  • 41. Single-Cell Sequencing Technology in Oncology: Applications for Clinical Therapies and Research.
    Ye B; Gao Q; Zeng Z; Stary CM; Jian Z; Xiong X; Gu L
    Anal Cell Pathol (Amst); 2016; 2016():9369240. PubMed ID: 27313981
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insights on the "Why, When, and How" of Integrating Molecular Testing in Anatomic Pathology Practice: Dedicated to the Memory of Gregory J. Naus, MD (1951-2015).
    Ionescu DN
    Arch Pathol Lab Med; 2016 Aug; 140(8):746-7. PubMed ID: 27472232
    [No Abstract]   [Full Text] [Related]  

  • 43. Molecular diagnostics for personal medicine using a nanopore.
    Mirsaidov UM; Wang D; Timp W; Timp G
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(4):367-81. PubMed ID: 20564464
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deploying whole genome sequencing in clinical practice and public health: meeting the challenge one bin at a time.
    Berg JS; Khoury MJ; Evans JP
    Genet Med; 2011 Jun; 13(6):499-504. PubMed ID: 21558861
    [No Abstract]   [Full Text] [Related]  

  • 45. An interview with Manuel Salto-Tellez on diagnostic pathology: the future is morphomolecular.
    Salto-Tellez M; Raison C
    Expert Rev Mol Diagn; 2015 May; 15(5):585-8. PubMed ID: 25838030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Next-generation sequencing of plasma/serum DNA: an emerging research and molecular diagnostic tool.
    Lo YM; Chiu RW
    Clin Chem; 2009 Apr; 55(4):607-8. PubMed ID: 19233905
    [No Abstract]   [Full Text] [Related]  

  • 47. The Journal of Molecular Diagnostics: 20 Years of Clinical Innovation.
    O'Leary TJ
    J Mol Diagn; 2019 Nov; 21(6):935-937. PubMed ID: 31635796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Next-generation sequencing and the cytopathologist.
    Dumur CI; Kraft AO
    Cancer Cytopathol; 2015 Feb; 123(2):69-70. PubMed ID: 25557465
    [No Abstract]   [Full Text] [Related]  

  • 49. 'Long distance sequencer' method; a novel strategy for large DNA sequencing projects.
    Hagiwara K; Harris CC
    Nucleic Acids Res; 1996 Jun; 24(12):2460-1. PubMed ID: 8710525
    [No Abstract]   [Full Text] [Related]  

  • 50. Diagnostic Molecular Cytopathology - a further decade of progress.
    Salto-Tellez M
    Cytopathology; 2015 Oct; 26(5):269-70. PubMed ID: 26399860
    [No Abstract]   [Full Text] [Related]  

  • 51. [Use of tissue matrix technology in contemporary diagnostics and research].
    Khramtsov AI; Khramtsova GF; Khmel'nitskaia HM
    Vopr Onkol; 2010; 56(2):240-4. PubMed ID: 20552905
    [No Abstract]   [Full Text] [Related]  

  • 52. Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.
    Sakai K; Tsurutani J; Yamanaka T; Yoneshige A; Ito A; Togashi Y; De Velasco MA; Terashima M; Fujita Y; Tomida S; Tamura T; Nakagawa K; Nishio K
    PLoS One; 2015; 10(5):e0121891. PubMed ID: 25954997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of an integrated clinical workflow for targeted next-generation sequencing of low-quality tumor DNA using a 51-gene enrichment panel.
    Choudhary A; Mambo E; Sanford T; Boedigheimer M; Twomey B; Califano J; Hadd A; Oliner KS; Beaudenon S; Latham GJ; Adai AT
    BMC Med Genomics; 2014 Nov; 7():62. PubMed ID: 25395014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Technical strategy for monozygotic twin discrimination by single-nucleotide variants.
    Sun W; Wang Z; Wen S; Huang A; Li H; Jiang L; Feng Q; Fan D; Tian Q; Han D; Liu X
    Int J Legal Med; 2024 May; 138(3):767-779. PubMed ID: 38197923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ECNano: A cost-effective workflow for target enrichment sequencing and accurate variant calling on 4800 clinically significant genes using a single MinION flowcell.
    Leung AW; Leung HC; Wong CL; Zheng ZX; Lui WW; Luk HM; Lo IF; Luo R; Lam TW
    BMC Med Genomics; 2022 Mar; 15(1):43. PubMed ID: 35246132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of rare variants implicated in schizophrenia using next-generation sequencing.
    Rhoades R; Jackson F; Teng S
    J Transl Genet Genom; 2019; 3(1):1-20. PubMed ID: 33981965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancer.
    Kaur P; Porras TB; Ring A; Carpten JD; Lang JE
    Sci Rep; 2019 Feb; 9(1):1482. PubMed ID: 30728399
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    Valentini V; Zelli V; Rizzolo P; Silvestri V; Alimandi M; D'Aloia MM; Giustini S; Calvieri S; Richetta AG; Monteleone G; Ottini L
    Clin Case Rep; 2018 Jul; 6(7):1358-1363. PubMed ID: 29988677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics.
    Schwarz UI; Gulilat M; Kim RB
    Cold Spring Harb Perspect Med; 2019 Feb; 9(2):. PubMed ID: 29844222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Workflow optimization of whole genome amplification and targeted panel sequencing for CTC mutation detection.
    Liu HE; Triboulet M; Zia A; Vuppalapaty M; Kidess-Sigal E; Coller J; Natu VS; Shokoohi V; Che J; Renier C; Chan NH; Hanft VR; Jeffrey SS; Sollier-Christen E
    NPJ Genom Med; 2017; 2():34. PubMed ID: 29263843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.